Cargando…

Therapeutic effect of a MUC1-specific monoclonal antibody-drug conjugates against pancreatic cancer model

BACKGROUND: Pancreatic cancer is one of the most aggressive malignancies without effective targeted therapies. MUC1 has emerged as a potential common target for cancer therapy because it is overexpressed in a variety of different cancers including the majority of pancreatic cancer. However, there ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Guang, Li, Lan, Liu, Mengnan, Chen, Chunyan, Wang, Guangze, Jiang, Zewei, Qin, Yaqian, He, Licai, Li, Hongzhi, Cao, Jiawei, Gu, Haihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793597/ https://www.ncbi.nlm.nih.gov/pubmed/36572921 http://dx.doi.org/10.1186/s12935-022-02839-w

Ejemplares similares

Detection of MUC1-Expressing Ovarian Cancer by C595 Monoclonal Antibody-Conjugated SPIONs Using MR Imaging
por: Shahbazi-Gahrouei, Daryoush, et al.
Publicado: (2013)

Monoclonal antibodies reacting with the MUC2 mucin core protein.
por: Devine, P. L., et al.
Publicado: (1993)

Monoclonal Antibodies Recognizing the Non-Tandem Repeat Regions of the Human Mucin MUC4 in Pancreatic Cancer
por: Jain, Maneesh, et al.
Publicado: (2011)

A Novel Monoclonal Antibody Specific for Sialylated MUC1 Mucin
por: Yamamoto, Masaya, et al.
Publicado: (1996)

Generation of Novel Anti-MUC1 Monoclonal Antibodies with Designed Carbohydrate Specificities Using MUC1 Glycopeptide Library
por: Naito, Shoichi, et al.
Publicado: (2017)

24‐Dehydrocholesterol reductase promotes the growth of breast cancer stem‐like cells through the Hedgehog pathway
por: Qiu, Ting, et al.
Publicado: (2020)

Zoledronic acid induces ferroptosis by reducing ubiquinone and promoting HMOX1 expression in osteosarcoma cells
por: Ren, Tianhao, et al.
Publicado: (2023)

Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
por: Radocha, Jakub, et al.
Publicado: (2021)

USP35, regulated by estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of estrogen receptor α
por: Cao, Jiawei, et al.
Publicado: (2021)

Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin
por: Gold, David V, et al.
Publicado: (2013)

Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody
por: Fang, Jun, et al.
Publicado: (2023)

Current and emerging monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies in treatment of lymphoma
por: Atallah-Yunes, Suheil Albert, et al.
Publicado: (2022)

Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer
por: Aithal, Abhijit, et al.
Publicado: (2018)

Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer
por: Stergiou, Natascha, et al.
Publicado: (2019)

Tiliroside Combined with Anti-MUC1 Monoclonal Antibody as Promising Anti-Cancer Strategy in AGS Cancer Cells
por: Radziejewska, Iwona, et al.
Publicado: (2023)

Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate
por: Butt, Mohammed Adil, et al.
Publicado: (2017)

The development and characterisation of porphyrin isothiocyanate–monoclonal antibody conjugates for photoimmunotherapy
por: Hudson, R, et al.
Publicado: (2005)

A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody–Drug Conjugate for Targeting Melanoma
por: Shi, Jing, et al.
Publicado: (2023)

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
por: He, Licai, et al.
Publicado: (2017)

Characterization of novel neutralizing mouse monoclonal antibody JM1-24-3 developed against MUC18 in metastatic melanoma
por: Feng, Runhua, et al.
Publicado: (2020)

Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
por: Picco, Gianfranco, et al.
Publicado: (2014)

Site-specific labeling of an anti-MUC1 antibody: probing the effects of conjugation and linker chemistry on the internalization process
por: Xu, Hongjiao, et al.
Publicado: (2019)

Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein.
por: Apostolopoulos, V., et al.
Publicado: (1993)

Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates
por: Carcenac, M, et al.
Publicado: (2001)

Antidermatophytic activity of some newly synthesized arylhydrazonothiazoles conjugated with monoclonal antibody
por: Ouf, Salama A., et al.
Publicado: (2020)

Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells
por: Senapati, Shantibhusan, et al.
Publicado: (2011)

ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody
por: Sharma, Sai Kiran, et al.
Publicado: (2022)

A Novel Fluoroimmunoassay for Detecting Ruscogenin with Monoclonal Antibodies Conjugated with CdSe/ZnS Quantum Dots
por: Zhang, Hongwei, et al.
Publicado: (2017)

Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
por: Arias-Pinilla, Gustavo A., et al.
Publicado: (2021)

Anti-MUC1 Monoclonal Antibody (C595) and Docetaxel Markedly Reduce Tumor Burden and Ascites, and Prolong Survival in an in vivo Ovarian Cancer Model
por: Wang, Li, et al.
Publicado: (2011)

Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas
por: Yokoyama, Seiya, et al.
Publicado: (2016)

Rise and Fall of an Anti-MUC1 Specific Antibody
por: Thie, Holger, et al.
Publicado: (2011)

Efficacy and Specificity of a Monoclonal Antibody‐Drug Conjugate in Chemotherapy by Intratumoral Injection
por: Kitamura, Kazuya, et al.
Publicado: (1992)

Production, Binding and Cytotoxicity of Human/Mouse Chimeric Monoclonal Antibody‐Neocarzinostatin Conjugate
por: Yamaguchi, Toshiharu, et al.
Publicado: (1993)

Studies on polyethylene glycol-monoclonal antibody conjugates for fabrication of nanoparticles for biomedical applications
por: Fisusi, Funmilola, et al.
Publicado: (2020)

Differences in MUC4 Expression in Pancreatic Cancers and Pancreatic Cysts in Egypt
por: Etekpo, Asserewou, et al.
Publicado: (2018)

Biodistribution of Neocarzinostatin Conjugated to Chimeric Fab Fragments of the Monoclonal Antibody A7 in Nude Mice Bearing Human Pancreatic Cancer Xenografts
por: Otsuji, Eigo, et al.
Publicado: (1994)

A New Monoclonal Antibody Demonstrates That Muc4, the Intramembrane Ligand for Erbb2/Her2/Neu, Is Overexpressed in Multiple Carcinomas
por: Zhang, Jin, et al.
Publicado: (2002)

Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity
por: Gong, Ying, et al.
Publicado: (2021)

Therapeutic monoclonal antibody for sporotrichosis
por: Almeida, Sandro R.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v4o91b04m5nle0qk9e7qvst43i